Find Your Ahahaha Moments! And Unlock the Power of Humor - Sponsored by Castle Biosciences
Apr 21, 2021 8:00am ‐ Apr 21, 2021 9:00am
Identification: GS101
Credits: None available.
The Power of Humor. A funny, empowering, and interactive talk. NOT just another Power Point Presentation- Finally, somebody is doing a "Powerless Pointless Presentation" LOL. Humor, it’s not just for fun anymore!
- Describe how humor reduces pain, anxiety, fear, stress, and impacts on the immune response.
- Explain how humor facilitates creative problem solving.
- Elaborate on the experiential benefits of humor and laughter.
Pediatric Derm Emergencies
Apr 21, 2021 9:30am ‐ Apr 21, 2021 10:30am
Identification: GS111
Credits: None available.
An irritable child, child that does not want to be carried, a subtle rash or eczema that is no longer responding to the daily treatments a can all be subtle signs of an impending pediatric dermatological emergency. Staphylococcal Scalded Skin Syndrome, eczema herpeticum, Stevens Johnson Syndrome, toxic epidermolysis bullosa, meningococcemia are all diagnoses that cause fear in pediatric nurses and providers. Knowing the subtle signs and symptoms of these conditions and others can expedite the parents ability to get the child optimal care. This presentation will provide clinical vignettes of pediatric patients and their clinical signs and symptoms of emergency pediatric dermatological conditions.
- Identify subtle signs of pediatric dermatological emergencies to facilitate treatment initiation.
- Analyze skin conditions commonly seen in pediatric population including Eczema herpeticum, Staph scalded skin syndrome, Stevens Johnson, and Toxic epidermal necrolysis.(RX 15 minutes)
- Discuss pharmacotherapeutic interventions frequently prescribed in these conditions including dosing, application and monitoring.
Its Not Just Diaper Rash
Apr 21, 2021 10:45am ‐ Apr 21, 2021 11:45am
Identification: GS121
Credits: None available.
Just because the rash is in the diaper area does not mean it is just a diaper rash. Dermatology nurses and nurse practitioners are presented with patients with a diaper rash that is not responding to usual and customary treatments by the patient's primary care provider. Irritant contact dermatitis, Jacquet's dermatitis, allergic contact dermatitis, bacterial and fungal dermatitis, eczematous dermatitis and other forms of diaper dermatitis will be presented through patient vignettes.
- Compare and analyze the common differential diagnoses for diaper dermatitis.
- Assess the unique clinical assessment features in diaper dermatitis.
- Describe the pharmacotherapeutic modalities for prescribing, dosing and application of topicals indicated for diaper dermatitis. (RX 15 minutes)
A Treatment Option for Patients with Uncontrolled Moderate-to-Severe Atopic Dermatitis. Sponsored by Regeneron/Sanofi
Apr 21, 2021 12:00pm ‐ Apr 21, 2021 1:00pm
Identification: GS131
Credits: None available.
Learn more about a treatment that may help your appropriate atopic dermatitis patients with uncontrolled moderate-to-severe atopic dermatitis.
Optimizing Flow in Mohs Surgery During a Pandemic
Apr 21, 2021 1:15pm ‐ Apr 21, 2021 2:15pm
Identification: GS141
Credits: None available.
Mohs Surgery needed to act quickly during the COVID pandemic in 2020 to reschedule and treat 600 plus skin cancers. There were several successful tactics that allowed this to happen in 1.5 months time and improved flow to extent of being able to add additional cases daily.
- Describe how a respiratory viral pandemic can result in patient flow challenges for Mohs surgery patients.
- Configure a workable, safe patient flow action plan for Mohs patients during a pandemic.
- Identify the importance of debriefing to evaluate the effectiveness of Mohs surgery patient flow during a pandemic.
Raising Awareness of Topical Steroid Withdrawal (TSW) Syndrome: Patient Impact and Caregiver Responsibility
Apr 21, 2021 2:45pm ‐ Apr 21, 2021 3:45pm
Identification: GS151
Credits: None available.
Topical Steroid Withdrawal Syndrome is often mistaken for “worsening eczema”, contact dermatitis, or an allergic reaction. We need to prepare nurses to recognize TSW Syndrome risk factors during assessment, including which questions to ask during intake. Nurses also need to understand the protracted nature of this disease, and the importance of maintaining a working relationship with the patient, to best serve this often misunderstood, under served patient population. The tendency of this population to never return to the office after a negative interaction with medical staff can not be underestimated.
- Identify important assessment details for Topical Steroid Withdrawal (TSW), including but not limited to signs, symptoms, prevalence and current treatments.
- Describe in detail the “5 Rights” of monitoring, medication reconciliation and tracking actual use of topical steroids.
- Discuss the importance of effective communication and therapeutic relationships when managing clients on topical steroids.
Incorporating Diagnostic & Prognostic Gene Expression Profile Tests in the Management of Skin Cancer. Sponsored by Castle Biosciences
Apr 21, 2021 4:00pm ‐ Apr 21, 2021 5:00pm
Identification: GS161
Credits: None available.
The Art of Diagnosis and Management of Dermatologic Diseases in Skin of Color
Apr 22, 2021 8:00am ‐ Apr 22, 2021 9:00am
Identification: GS201
Credits: None available.
We will discuss the impact on accurate diagnosis in skin of color. Skin color matters and the importance of recognizing early erythema will save lives.
- Describe inflammatory and neoplastic diseases in Fitzpatrick skin type I-VI.
- Assess the variations and difference in skin colors with the Fitzpatrick Skin Type with clarification on the science of skin color.
- Clarify how conditions such as anemia, hypoxemia and internal diseases can result in color changes in the skin.
New treatments/Medications/JAK inhibitors/Clinical trials
Apr 22, 2021 9:30am ‐ Apr 22, 2021 10:30am
Identification: GS211
Credits: None available.
JAK inhibitors are small molecules with huge promise in Dermatology. In this lecture, we will discuss the mechanism of JAK inhibitors, identify the current FDA approved indications of JAK inhibitors, and explore future uses of JAK inhibitors in Dermatology.
- Explain the pharmacokinetics and indications for Janus Kinase inhibitors. (20 minutes RX)
- Discuss dosing indications, laboratory monitoring and evaluation effectiveness in patients prescribed to a JAK inhibitor. (20 minutes RX)
- Identify at least three (3) adverse reactions from a JAK inhibitor with required interventions. (20 minutes RX)
Teledermatology; Maintain Quality of Care and Patient Satisfaction in a Virtual Visit
Apr 22, 2021 10:45am ‐ Apr 22, 2021 11:45am
Identification: GS221
Credits: None available.
Virtual visits were already becoming more widely used in health care as a means to expand access to care. The advent of the COVID-19 pandemic pushed the discipline in to the essential range. To facilitate continuity of care and limit exposure, many dermatology offices launched Teledermatology programs. This lecture looks at existing and emerging research on successful implementation, evaluation, and maintenance of Teledermatology in practice. We will also review available literature looking at health outcomes and patient satisfaction.
- Describe the benefits of teledermatology, to patients and providers during the evolving COVID-19 pandemic.
- Clarify the components of teledermatology including electronic and telecommunications technologies and use of two-way, real-time interactive audio and video between provider and patient.
- Discuss how virtual patient communication is another part of telehealth used to provide quality assessment and evaluation including consultation between provider and patient or between different providers.